|

Exemestane 25 MG Clinical Trials

3 actively recruiting trials

Also known as: Exemestane

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 1

Top Sponsors

  • SAPU NANO (US) LLC1
  • European Organisation for Research and Treatment of Cancer - EORTC1
  • Andrea DeCensi1

Indications

  • Breast Cancer3
  • Cancer3
  • Liver Disease1
  • Tuberous Sclerosis Complex (TSC)1
  • Stage III Breast Cancer1

Other3 trials

Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
Phase 3
Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.
Phase 2
Sapu003 in Advanced mTOR-sensitive Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.